MicroRNA-9 Regulates Non-small Cell Lung Cancer Cell Invasion and Migration by Targeting Eukaryotic Translation Initiation Factor 5A2
Overview
Authors
Affiliations
MicroRNAs (miRNAs) play a critical role in cancer development and progression. Bioinformatics analyses has identified eukaryotic translation initiation factor 5A2 (eIF5A2) as a target of miR-9. In this study, we attempted to determine whether miR-9 regulates non-small cell lung cancer (NSCLC) cell invasion and migration by targeting eIF5A2 We examined eIF5A2 expression using reverse transcription-quantitative PCR (RT-qPCR) and subsequently transfected A549 and NCI-H1299 NSCLC cells with a miR-9 mimic or miR-9 inhibitor to determine the migration and invasive capability of the cells via wound healing assay and Transwell invasion assay, respectively. E-cadherin and vimentin expression was detected with western blotting. The miR-9 mimic significantly reduced NSCLC cell invasive and metastatic ability, and the miR-9 inhibitor enhanced NSCLC cell migration activity, increasing the number of migrated cells. There was no significant difference between the negative control siRNA and miR-9 mimic groups after knockdown of eIF5A2; western blotting showed that miR-9 regulated E-cadherin and vimentin expression. These data show that miR-9 regulates NSCLC cell invasion and migration through regulating eIF5A2 expression. Taken together, our findings suggest that the mechanism of miR-9-regulated NSCLC cell invasion and migration may be related to epithelial-mesenchymal transition.
Bordbar F, Rigi A, Mastanabad M, Rohani F, Ghaedi E, Dhiaa S Cell Biochem Biophys. 2024; .
PMID: 39663279 DOI: 10.1007/s12013-024-01570-9.
Clinical significance of miR-9-5p in NSCLC and its relationship with smoking.
Zhang T, Duan X, Cui Y, Zhang Y, Gu M, Wang Z Front Oncol. 2024; 14:1376502.
PMID: 38628672 PMC: 11018953. DOI: 10.3389/fonc.2024.1376502.
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients.
Sanchez-Cabrero D, Garcia-Guede A, Burdiel M, Pernia O, Colmenarejo-Fernandez J, Gutierrez L Int J Mol Sci. 2023; 24(14).
PMID: 37511221 PMC: 10380700. DOI: 10.3390/ijms241411464.
Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
Qiu X, Chen Y, Zhu X, Gong Z, Yu F, Zhang P Asian Pac J Cancer Prev. 2023; 24(4):1275-1287.
PMID: 37116150 PMC: 10352730. DOI: 10.31557/APJCP.2023.24.4.1275.
Cheng Y, Wang S, Mu X Transl Cancer Res. 2022; 10(12):5159-5173.
PMID: 35116366 PMC: 8798158. DOI: 10.21037/tcr-21-1468.